Abstract
Although decreased in incidence, fetal anemia remains a serious complication in pregnancy and is associated with a clinically significant perinatal mortality and morbidity. Ultrasound-guided intrauterine transfusion (IUT) is now considered to be the most successful therapy for fetal anemia secondary to red cell alloimmunization. As a result of a cumulative clinical experience, IUT has been expanded to apply as a therapy for multiple fetal indications including parvovirus B19 infection, fetomaternal hemorrhage, and placental chorioangiomas. Current indications, complications, and long-term outcomes of IUT therapy will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Intravascular Techniques for FBS
Bang J, Bock JE, Trolle D. Ultrasound guided fetal intravenous transfusion for severe rhesus hemolytic disease. Br Med J. 1982;284:373–4.
Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of fifty-three cases. Am J Obstet Gynecol. 1983;146:985–7.
Rodeck CH, Campbell S. Umbilical cord insertion as a source of pure fetal blood for prenatal diagnosis. Lancet. 1979;1:1244–5.
Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol. 2013;209(3):170–80.
Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol. 1999;7:283–6.
Delamare C, Carbonne B, Heim N, et al. Detection of hepatitis C virus RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol. 1999;31:416–20.
Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol. 2005;193:437–42.
Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol. 2001;184:1514–20.
Tangshewinsirikul C, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongsong T. Effect of cord puncture site in cordocentesis at mid-pregnancy on pregnancy outcomes. Prenat Diagn. 2001;31:861–64.
Tongsong T, Wanapirak C, Kunavikatikul C, Sirirchotiyakul S, Piyamongkol W, Chanprapaph P. Cordocentesis at 16–24 weeks of gestation: experience of 1,320 cases. Prenat Diagn. 2000;20:224.
Aina-Mumuney AJ, Holcroft CJ, Blakemore KJ, et al. Intrahepatic vein for fetal blood sampling: one center's experience. Am J Obstet Gynecol. 2008;198:387.e1–e6.
Boulout P, Deschamps F, Lefort G, et al. Pure fetal blood samples obtained by cordocentesis: technical aspects of 322 cases. Prenat Diagn. 1990;10:93–100.
Copel JA, Grannum PA, Harrison D, Hobbins JC. The use of intravenous pancuronium bromide to produce fetal paralysis during intravascular transfusion. Am J Obstet Gynecol. 1988;158:170–1.
Moise KJ, Deter RL, Kirshon B, Adam K, Patton DE, Carpenter RJ. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization. Obstet Gynecol. 1989;74:905–8.
Bernstein HH, Chitkara U, Plosker H, Gettes M, Berkowitz RL. Use of atracurium besylate to arrest fetal activity during intrauterine intravascular transfusions. Obstet Gynecol. 1988;72:813–16.
Leveque C, Murat I, Toubas F, Poissonnier MH, Brossard Y, Saint-Maurice C. Fetal neuromuscular blockade with vecuronium bromide: studies during intravascular intrauterine transfusion in isoimmunized pregnancies. Anesthesiology. 1992;76:642–44.
Liao C, Wei J, Li Q, Li L, Li J, Li D. Efficacy and safety of cordocentesis for prenatal diagnosis. Int Gyencol Obstet. 2006;93:13–7.
Boupaijit K, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongsong T. Effect of placenta penetration during cordocentesis at mid pregnancy on fetal outcomes. Prenat Diagn. 2012;32:83–7.
Volume Calculations
Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, Schenone MH. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia-diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697–710.
Moise KJ, Whitecar PW. Antenatal therapy for hemolytic disease. In: Hadley A, Soothill P, editors. Alloimmune disorders of pregnancy. Anemia, thrombocytopenia and neutropenia in the fetus and newborn. Cambridge, UK: Cambridge University Press; 2002.
Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol. 1992;79:390–93.
Complications: ND Outcomes
DeJong EP, Lindenberg IT, van Klink JM, Oepkes D, van Kamp IL, Wlather FJ, Lopriore E. Intrauterine transfusion for parvovirus B19 infection: long term neurodevelopmental outcome. Am J Obstet Gynecol. 2012;206:e1–5.
Doyle LW, Kelly EA, Rickards AL, Ford GW, Callanan C. Sensorineural outcome at two years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol. 1993;81:931–5.
Stewart G, Day RE, Del PC, Whittle MJ, Turner TL, Holland BM. Developmental outcome after intravascular intrauterine transfusion for rhesus hemolytic disease. Arch Dis Child Fetal Neonatal Ed. 1994;70:F52–3.
Janssens HM, de Haan MJ, van Kemp IL, Brand R, Kanhai HH, Veen S. Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr. 1997;131:373–80.
Hudon L, Moise KJ, Hegemier SE, Hill RM, Moise AA, Smith EO, et al. Long term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol. 1998;81:931–35.
Grab D, Paulus WE, Bommer A, Bucjk G, Terinde R. Treatment of fetal erythroblastosis by intravascular transfusions: outcomes at 6 years. Obstet Gynecol. 1999;93:165–8.
Farrant B, Battin M, Roberts A. Outcomes of infants receiving in utero transfusions for hemolytic disease. N Z Med J. 2001;114:400–3.
Harper DC, Swigle HM, Weiner CP, Bonthius DJ, Aylward GP, Widness JA. Long term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol. 2006;195:192–200.
Weisz B, Rosenbaum O, Chayen B, Peltz R, Feldman B, Lipitz S. Outcome of severely anemic fetuses treated by intrauterine transfusions. Arch Dis Child Fetal Neonatal Ed. 2009;94:F201–4.
Lindenberg ITM, Smits-Wintjens VE, Van Klink JMM, Verduin E, Van Kamp IL, Walther FJ, et al. Long term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol. 2012;206:141.e1–8.
Van Klink JMM, Koopman HM, Oepkes D, Walther FJ, Lopriore E. Long term neurodevelopmental outcome after intrauterine transfusion for fetal anemia. Early Hum Dev. 2011;87:589–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Khalek, N. (2017). Intrauterine Transfusions. In: Sesok-Pizzini, D. (eds) Neonatal Transfusion Practices. Springer, Cham. https://doi.org/10.1007/978-3-319-42764-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-42764-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42762-1
Online ISBN: 978-3-319-42764-5
eBook Packages: MedicineMedicine (R0)